Literature DB >> 8615081

Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions.

H Tomimoto1, I Akiguchi, T Suenaga, H Wakita, S Nakamura, J Kimura, H Budka.   

Abstract

In the brains of ine cases with cerebrovascular disease, one with mixed dementia, one with amyloid angiopathy and two non-neurological controls, we found three cases with focal accumulation of apolipoprotein E (apo-E) in dystrophic axons and accompanying macrophages. Since amyloid precursor protein (APP) and chromogranin A (CgA) accumulate after axonal damages, and are sensitive markers of the white matter lesions, the regional distribution of apo-E was compared to that of APP and CgA. apo-E-immunoreactive axons were present in the periphery of an infarction with neighboring macrophages, but not in mild white matter lesions that contained APP- or CgA-immunoreactive fiber bundles. The results suggest a role of apo-E in recycling cholesterol and other membrane components via macrophages into remodeling neurites in the brain, but this phenomenon is restricted to the periphery of infarction and may be less prominent than in the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8615081     DOI: 10.1007/bf00318573

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  40 in total

1.  Temporal profiles of accumulation of amyloid beta/A4 protein precursor in the gerbil after graded ischemic stress.

Authors:  H Tomimoto; H Wakita; I Akiguchi; S Nakamura; J Kimura
Journal:  J Cereb Blood Flow Metab       Date:  1994-07       Impact factor: 6.200

2.  Denervated sheath cells secrete a new protein after nerve injury.

Authors:  J H Skene; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

3.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

4.  Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study.

Authors:  S H Han; G Einstein; K H Weisgraber; W J Strittmatter; A M Saunders; M Pericak-Vance; A D Roses; D E Schmechel
Journal:  J Neuropathol Exp Neurol       Date:  1994-09       Impact factor: 3.685

5.  Expression of apolipoprotein E during nerve degeneration and regeneration.

Authors:  M J Ignatius; P J Gebicke-Härter; J H Skene; J W Schilling; K H Weisgraber; R W Mahley; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

6.  Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat.

Authors:  D T Stephenson; K Rash; J A Clemens
Journal:  Brain Res       Date:  1992-10-09       Impact factor: 3.252

7.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments.

Authors:  E Englund; A Brun
Journal:  Histopathology       Date:  1990-05       Impact factor: 5.087

9.  Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain.

Authors:  E Kida; R Pluta; A S Lossinsky; A A Golabek; N H Choi-Miura; H M Wisniewski; M J Mossakowski
Journal:  Brain Res       Date:  1995-03-20       Impact factor: 3.252

10.  Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury.

Authors:  S M Gentleman; M J Nash; C J Sweeting; D I Graham; G W Roberts
Journal:  Neurosci Lett       Date:  1993-10-01       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.